The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has filed a Form 8.3 with the Irish Takeover Panel concerning its position in Mural Oncology plc. This disclosure, dated September 26, 2025, outlines Vanguard's interests in Mural Oncology's securities. Notably, Vanguard controls 646,536 ordinary shares, which equates to a 3.74% stake in the company.

In recent activity, Vanguard purchased 32 ordinary shares at a unit price of $2.09. This purchase is part of routine transactions disclosed under the Irish Takeover Panel rules. No additional derivatives or options have been noted in the filing. Furthermore, there are no indemnity, option arrangements, or agreements affecting the voting or future securities dealings reported by Vanguard.

The disclosure, as per the Irish regulations, confirms Vanguard's position in the securities market regarding Mural Oncology. No supplemental Form 8 has been attached to this filing.